Today: 13 June 2026
HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors
24 April 2026
2 mins read

HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

April 24, 2026, Nashville — 16:02 CDT.

HCA Healthcare shares slipped Friday. The hospital operator managed to edge past Wall Street’s first-quarter profit expectations, but investors zeroed in on weaker patient volumes and early evidence that changes in the insurance market are starting to take a toll.

The stock dropped 8.8% to $432.46, market data showed. Tenet Healthcare and Universal Health Services didn’t escape the pressure—those shares slid roughly 4% and 3.8% apiece, after HCA’s update heightened concerns over volume and payer-mix risk across the sector.

Timing comes into play here. HCA, a giant among U.S. hospital operators, often signals trends in patient volumes, labor expenses, and reimbursement strain. Its latest numbers dropped just as hospitals contend with fallout from shifts to Affordable Care Act exchange plans—those are the ones where individuals pick up their own coverage—and a bump in the share of uninsured treatments, which typically prove tougher to recoup.

First-quarter revenue landed at $19.109 billion for the company, a 4.3% increase from the same stretch last year. Net income attributable to HCA hit $1.620 billion, translating to $7.15 per diluted share. Adjusted EBITDA—a number stripping out interest, taxes, depreciation, and a handful of other items—came in 1.9% higher at $3.802 billion.

HCA flagged a lack of the typical seasonal bump from respiratory illnesses this time around. Respiratory admissions slumped 42% year-over-year, while ER visits tied to those conditions slid 32%. The company also pointed to a January winter storm that dragged down volumes in several markets — namely Texas, Tennessee, North Carolina and Virginia.

Chief Executive Sam Hazen described the year’s opening stretch as a “dynamic environment,” framing the respiratory and storm impacts as first-quarter matters. Chief Financial Officer Mike Marks told analysts those two items knocked an estimated $180 million off adjusted EBITDA, but emphasized HCA considered them “temporal and not structural.” The Motley Fool

The tape may have looked soft, but numbers told a different story. Same-facility admissions picked up 0.9%, and equivalent admissions—HCA’s own metric pooling inpatients with adjusted outpatient activity—gained 1.3%. Emergency room visits nudged 0.3% higher as well.

HCA stuck to its 2026 outlook, still projecting revenue between $76.5 billion and $80.0 billion, adjusted EBITDA in a $15.55 billion to $16.45 billion range, and earnings per share of $29.10 to $31.50. According to the company, Medicaid supplemental programs—state payments that boost hospital reimbursement—helped cushion the impact from lighter patient volumes.

Still, not everyone was reassured. Barclays’ Andrew Mok flagged the quarter as a “somewhat concerning start to the year,” and noted risks if headwinds from the Affordable Care Act or commercial insurance trends pick up. J.P. Morgan’s Benjamin Rossi pointed out that HCA’s steady outlook matches its habit of not changing first-quarter guidance, even when volumes lag early on. Reuters

There’s a risk volume weakness might stick around longer than management anticipates. Marks is sticking with the $600 million to $900 million full-year hit tied to exchange-plan changes, saying it’s “a little early” to know if results will end up toward the low end. Hazen, for his part, said Medicaid conversion trends haven’t settled down: “We just need a little bit more time to judge it.” The Motley Fool

Payer behavior is still weighing on results. Marks cited persistently high denial rates and underpayments, especially for Medicare Advantage, the private Medicare option. “The denials and underpayments are still really high,” he said. HCA’s response? More tech, more resources—tools Marks says are helping limit the hit to earnings. The Motley Fool

HCA continued buying back its own stock, snapping up 3.157 million shares for $1.571 billion during the quarter. The board also signed off on a 78-cent quarterly dividend, set for payout on June 30 to holders as of June 16. As of March’s close, the company operated 189 hospitals along with roughly 2,600 ambulatory care locations.

Stock Market Today

  • Retail Investors Eye SpaceX Shares as Mega IPO Launches
    June 12, 2026, 11:20 PM EDT. Retail investors closely monitored their brokerage accounts on Friday to assess their allocations in SpaceX's large-scale initial public offering (IPO). With SpaceX going public, individual investors showed strong interest in owning small stakes in the aerospace giant. Others moved quickly to purchase shares on the open market on the IPO's debut day, signaling robust demand. This trend highlights growing retail participation in blockbuster tech IPOs, where investors aim to capitalize on high-growth potentials with relatively small investments.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Applied Optoelectronics Stock Jumps 17%: Why AAOI’s AI Optics Rally Faces a May Test
Previous Story

Applied Optoelectronics Stock Jumps 17%: Why AAOI’s AI Optics Rally Faces a May Test

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus
Next Story

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

Go toTop